The new MHRA’s framework for clinical studies
By Giuliana Miglierini The repositioning of the United Kingdom as a global leader for clinical development of medicinal…
The Windsor Framework
On 27 February 2023, UK Prime Minister Rishi Sunak and the European Commission President Ursula von der Leyen…
ICMRA report on best practices against antimicrobial resistance
by Giuliana Miglierini Antimicrobial resistance (AMR) is the consequence of mutations that allow microbes to survive pharmacological treatment.…
Current inspection trends and new approaches to the monitoring of post-inspection activities
by Giuliana Miglierini The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published its Annual Regulatory GMP/GDP…
A golden era for UK’s life sciences and a new Code of practice for its pharmaceutical industry
by Giuliana Miglierini Less than a year has gone since the Brexit, and the UK innovation landscape is…